Warning over commonly prescribed drug millions take every day
A pharmacist has issued a list of symptoms to watch out for Neil Shaw Assistant Editor 07:41, 15…
75 types of meds; yearly limit at P20,000
File photo MANILA, Philippines — PhilHealth members will soon have access to 75 types of medicines for free…
Cost of Mounjaro set to almost triple but people may still be able to get discounts
The cost of paying for Mounjaro in the UK is likely to rise significantly. Manufacturer Eli Lilly said…
Mounjaro weight-loss drug price to almost triple in UK after Trump complaint
The price of popular weight-loss jab Mounjaro will nearly triple after the US-owned company equalised costs in markets…
Warning over ‘life-threatening’ fake Ozempic jabs sold by bogus online pharmacies
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
P20-K free medicines available for PhilHealth members – ABS-CBN
P20-K free medicines available for PhilHealth members ABS-CBNPrescription for change Philstar.comProgress in healthcare reforms BusinessWorld – BusinessWorld OnlineZero balance billing now…
Is Benadryl Safe? Why Experts Are Concerned About This Allergy Med
You may want to reconsider reaching for the antihistamine Benadryl at the first sign of sneezing, itching, or…
Public urged not to purchase medicines online – Highland Radio
Public urged not to purchase medicines online Highland RadioFaux-zempic danger: How to tell if YOUR jab is a convincing…
Retatrutide: The newest weight loss drug showing promise | Health
SHREVEPORT, La. – A new drug developed by Eli Lily works in a unique way compared to treatments…
Dapagliflozin tablets – changes to reimbursement from September 2025
Dapagliflozin 5mg and 10mg tablets will be moving from Category C to Category M in the September 2025…
2 Michigan doctors, staff charged in opioid distribution conspiracy
FDA Approves non-Opioid painkiller to combat addiction crisis The U.S. Food and Drug Administration has approved Journavx, a…
MHRA approves teplizumab to delay progression of type 1 diabetes
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 14 August 2025, approved teplizumab (Tzield) to delay…